Can Retinol Be Used During Pregnancy?

What Retinol Is and How It Works on Skin

Retinol is a vitamin A derivative that, once converted in the skin to retinoic acid, binds nuclear retinoid receptors and increases keratinocyte turnover and dermal collagen signaling — the same receptor-mediated mechanism that underlies both its cosmetic anti-aging benefits and the developmental concerns that make it a precaution during pregnancy. Because the pathway is the same regardless of whether retinoic acid is generated from an oral medication or a topical cosmetic ingredient, the precautionary logic is mechanistic rather than purely observational, as reviews of retinoid clinical efficacy and safety document.^[1]

The Historical Basis: Systemic Retinoid Teratogenicity

Lammer and colleagues' foundational 1985 research establishing retinoic acid embryopathy documented the well-established teratogenic risk associated with systemic (oral) retinoid exposure — specifically isotretinoin, prescribed for severe cystic acne — providing the historical scientific basis for the broader retinoid pregnancy precaution discussed extensively throughout this literature's pregnancy-safe skincare review. This systemic-exposure finding represents the original evidentiary foundation from which topical-exposure precautionary guidance was subsequently extended.^[2]

Direct Systematic Review Evidence for Topical Exposure Specifically

Kaplan and colleagues' systematic review and meta-analysis specifically and directly evaluated pregnancy outcomes following first-trimester topical retinoid exposure — moving beyond extrapolation from systemic exposure data into a rigorously synthesized evidence base addressing the topical exposure question most directly relevant to skincare-context retinol use. The meta-analysis, covering several hundred exposed pregnancies compared against unexposed controls, did not detect a statistically significant increase in major congenital malformations — an important, reassuring data point for anyone who used retinol before realizing they were pregnant — while the clinical recommendation to avoid topical retinoids during pregnancy remains standard practice given the severity of the outcome being guarded against and the relatively limited size of the available evidence base.^[4]

Which Retinoid Derivatives Should Be Avoided

The precaution generally extends to the full family of vitamin A derivatives used in skincare and dermatology, not retinol alone: retinol, retinaldehyde, retinyl palmitate and retinyl acetate (ester forms that convert to retinoic acid in skin), prescription tretinoin and adapalene, and — with the strongest, most directly documented risk — oral isotretinoin. Ingredient labels should be checked for any of these names before continuing a routine once pregnancy is confirmed or suspected.

How Pregnancy Changes the Skin Barrier

Hormonal shifts during pregnancy affect skin in ways that go beyond retinoid sensitivity alone: increased estrogen and progesterone can heighten skin reactivity and pigmentation response, while the skin barrier itself may become more sensitive to actives that were previously well tolerated. Tunzi and Gray's review of common skin conditions during pregnancy documents that hormone-related changes — including hyperpigmentation, altered sebum production, and increased vascular reactivity — are a normal and expected part of pregnancy, which is part of why a temporarily gentler, more barrier-focused routine (rather than simply removing retinol and changing nothing else) tends to serve pregnant skin better.^[6]

Extensive Real-World Topical Use Experience

Baldwin and colleagues' review of four decades of topical tretinoin use provides relevant, extensive real-world safety experience context, situating the pregnancy-specific precaution within the broader, well-established topical retinoid safety literature — reinforcing that the pregnancy-specific caution reflects a targeted, evidence-based precaution for this specific population rather than a broader, unsubstantiated concern about topical retinoid safety generally.^[5]

Safe Alternatives to Retinol During Pregnancy

Chien and colleagues' review of acne treatment in pregnancy provides directly relevant, practical clinical guidance for pregnant individuals managing acne without retinoid use, generally supporting topical azelaic acid or benzoyl peroxide as baseline therapy, with topical erythromycin or clindamycin as an option for inflammatory acne.^[7] For general anti-aging goals rather than acne specifically, Dhaliwal and colleagues' randomized, double-blind trial comparing bakuchiol against retinol found the two produced comparable improvements in wrinkle surface area and hyperpigmentation over twelve weeks, with bakuchiol showing better tolerability — supporting it as a genuinely evidence-backed, non-retinoid alternative for pregnancy rather than an untested substitute.^[8] Azelaic acid and standard-concentration AHA are also generally considered appropriate during pregnancy, discussed extensively in the dedicated pregnancy-safe skincare review elsewhere in this literature.

A Step-by-Step Pregnancy-Safe Skincare Routine

Contextualizing Methodology for Teratogenicity Research

Dolk and colleagues' large-scale registry research on lamotrigine exposure during pregnancy, while addressing an entirely different medication, provides relevant methodological context for how teratogenicity research is appropriately designed and interpreted at scale — using population-based congenital anomaly registries across many countries to detect or rule out an elevated malformation risk. This reinforces that the retinoid-pregnancy evidence base, and pregnancy teratogenicity research generally, reflects rigorous, appropriately designed research methodology rather than anecdotal or poorly controlled observation.^[3]

What Your Skin Is Telling You

"Pregnancy-related skin changes are common and mostly benign, but recognizing which signals are simply hormonal versus which warrant discontinuing an active ingredient or seeking guidance is a useful skill during this period."

Conclusion

Retinol avoidance during pregnancy is supported by both the historical foundation of systemic retinoid teratogenicity research and, more directly, systematic review evidence evaluating topical retinoid exposure in early pregnancy specifically — representing a genuinely evidence-based precautionary basis, with well-documented, effective pregnancy-safe alternatives (azelaic acid, bakuchiol, standard AHA) available for continued skincare management. For a pregnancy-safe skincare approach avoiding retinol appropriately, our pharmacist, Mine Ekber, is available for direct consultation via WhatsApp.

Frequently Asked Questions

Further Reading